Why AMD Shares Are Trading Higher By Over 9%; Here Are 20 Stocks Moving Premarket
Author: Avi Kapoor | July 31, 2024 05:46am
Shares of Advanced Micro Devices, Inc. (NASDAQ:AMD) shares rose sharply in today's pre-market trading following better-than-expected second-quarter earnings.
AMD reported quarterly earnings of 69 cents per share which beat the analyst consensus estimate of 68 cents per share. The company reported quarterly sales of $5.835 billion which beat the analyst consensus estimate of $5.724 billion, according to data from Benzinga Pro.
AMD shares jumped 9.1% to $151.01 in pre-market trading.
Here are some other stocks moving in pre-market trading.
Gainers
- Primech Holdings Ltd. (NASDAQ:PMEC) gained 114.8% to $1.13 in pre-market trading after gaining over 5% on Tuesday.
- Heramba Electric plc (NASDAQ:PITA) shares climbed 92.8% to $8.29 in pre-market trading after dipping around 49% on Tuesday.
- NuZee, Inc. (NASDAQ:NUZE) rose 79.4% to $6.64 in pre-market trading after gaining around 3% on Tuesday.
- Telesis Bio, Inc. (NASDAQ:TBIO) gained 39.8% to $5.52 in pre-market trading.
- Faraday Future Intelligent Electric Inc. (NASDAQ:FFIE) shares gained 33.1% to $0.4205 in pre-market trading after the company regained Nasdaq compliance.
- Powell Industries, Inc. (NASDAQ:POWL) gained 25.3% to $167.02 in pre-market trading after posting better-than-expected third-quarter results.
- BIMI Holdings Inc. (NASDAQ:BIMI) shares gained 22.8% to $0.48 in pre-market trading after dipping 66% on Tuesday.
- DallasNews Corporation (NASDAQ:DALN) shares gained 19.1% to $3.91 in pre-market trading after the company reported a year-over-year increase in second-quarter financial results.
- Vistra Corp. (NYSE:VST) gained 12.1% to $77.35 in pre-market trading after the company announced that the Nuclear Regulatory Commission has approved its request to extend the operation of Comanche Peak Nuclear Power Plant through 2053.
Losers
- FibroGen, Inc. (NASDAQ:FGEN) shares fell 40.2% to $0.6159 in pre-market trading. The company announced topline results from two late-stage trials evaluating the efficacy and safety of pamrevlumab in patients with pancreatic cancer and said its Precision Promise study in metastatic pancreatic cancer did not meet its primary endpoint.
- MacroGenics, Inc. (NASDAQ:MGNX) shares declined 24% to $3.99 in pre-market trading. The company announced a presentation of clinical data from the TAMARACK Phase 2 study of vobramitamab duocarmazine at the upcoming European Society for Medical Oncology Congress 2024.
- Jet.AI Inc. (NASDAQ:JTAI) fell 21.5% to $0.2631 in pre-market trading. Jet.AI announced expiration and successful results of exchange offer and consent solicitation relating to warrants.
- Velo3D, Inc. (NYSE:VLD) shares fell 20.6% to $2.20 in pre-market trading after declining 4% on Tuesday.
- Penumbra, Inc. (NYSE:PEN) shares fell 20.3% to $137.93 in pre-market trading after the company reported second-quarter financial results and cut its FY24 revenue guidance below estimates.
- Groupon, Inc. (NASDAQ:GRPN) shares declined 18.6% to $12.75 in pre-market trading following a second-quarter EPS miss.
- Definitive Healthcare Corp. (NASDAQ:DH) shares fell 17.6% to $4.71 in pre-market trading. Needham analyst Ryan MacDonald reiterated Definitive Healthcare with a Hold.
- O-I Glass, Inc. (NYSE:OI) fell 15.5% to $9.80 in pre-market trading after the company lowered its FY24 guidance.
- Lemonade, Inc. (NYSE:LMND) shares dipped 14.6% to $19.33 in pre-market trading following quarterly results.
- Tivic Health Systems, Inc. (NASDAQ:TIVC) shares fell 12.4% to $0.5056 in pre-market trading after dipping 18% on Tuesday.
Now Read This:
Posted In: AMD BIMI DALN DH FFIE FGEN GRPN JTAI LMND MGNX NUZE OI PEN PITA PMEC POWL TBIO TIVC VLD VST
